UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

JNJ-26481585, a Novel “Second-Generation” Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity

Clinical cancer research, 2009-11, Vol.15 (22), p.6841-6851

2009

Volltextzugriff (PDF)

Translational PK-PD modeling analysis of MCLA-128, a HER2/HER3 bispecific monoclonal antibody, to predict clinical efficacious exposure and dose

Investigational new drugs, 2018-12, Vol.36 (6), p.1006-1015

2018

Volltextzugriff (PDF)

814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A863-A863

2020

Volltextzugriff (PDF)

Phase I dose-escalation study of MCLA-158, a first-in-class bispecific antibody targeting EGFR and LGR5, in metastatic colorectal cancer (CRC)

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.62-62

2021

Volltextzugriff (PDF)

Abstract OT2-15-01: Updated analysis of MCLA-128 (zenocutuzumab), trastuzumab, and vinorelbine in patients (pts) with HER2 positive/amplified (HER2+) metastatic breast cancer (MBC) who progressed on previous anti-HER2 ADCs

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT2-15-01-OT2-15-01

2022

Volltextzugriff (PDF)

Population Pharmacokinetics of MCLA-128, a HER2/HER3 Bispecific Monoclonal Antibody, in Patients with Solid Tumors

Clinical pharmacokinetics, 2020-07, Vol.59 (7), p.875-884

2020

Volltextzugriff (PDF)

Abstract P185: Preliminary antitumor activity of MCLA-158, an IgG1 bispecific antibody targeting EGFR and LGR5, in advanced head and neck squamous cell carcinoma

Molecular cancer therapeutics, 2021-12, Vol.20 (12_Supplement), p.P185-P185

2021

Volltextzugriff (PDF)

The "Localist Turn" and "Local Identity" in Later Imperial China

Late imperial China, 2003-12, Vol.24 (2), p.1-50

Bol, Peter Kees

2003

Volltextzugriff (PDF)

First-in-human phase 1/2 study of MCLA-128, a full length IgG1 bispecific antibody targeting HER2 and HER3: Final phase 1 data and preliminary activity in HER2+ metastatic breast cancer (MBC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.2522-2522

2017

Volltextzugriff (PDF)

Clinical activity of MCLA-128 (zenocutuzumab), trastuzumab, and vinorelbine in HER2 amplified metastatic breast cancer (MBC) patients (pts) who had progressed on anti-HER2 ADCs

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3093-3093

2020

Volltextzugriff (PDF)

Clinical activity of MCLA-128 (zenocutuzumab) in combination with endocrine therapy (ET) in ER+/HER2-low, non-amplified metastatic breast cancer (MBC) patients (pts) with ET-resistant disease who had progressed on a CDK4/6 inhibitor (CDK4/6i)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.1037-1037

2020

Volltextzugriff (PDF)

Abstract CT050: A Phase I/II Study of MCLA-128, a full length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients with Solid Tumors

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT050-CT050

2016

Volltextzugriff (PDF)

Sung Dynasty uses of the I ching

1, 2014

Volltextzugriff (PDF)

Advances in Electronics and Electron Physics . vol. IX. L. Marton, Ed. Academic Press, New York, 1957. x +347 pp. Illus. $9

Science (American Association for the Advancement of Science), 1958-04, Vol.127 (3302), p.809-810

Bol, Kees

1958

Volltextzugriff (PDF)

THE VELOCITY OF LIGHT AS MEASURED BY THE RESONANT MICROWAVE CAVITY METHOD

BOL, KEES

1951

Volltextzugriff (PDF)

Advances in Electronics and Electron Physics. vol. IX

Science, 1958, Vol.127 (3302), p.809-810

Bol, Kees

1958

Volltextzugriff (PDF)

Robert A. Ellis Jr

Physics today, 1991-03, Vol.44 (3), p.86-88

1991

Volltextzugriff (PDF)

A Determination of the Speed of Light by the Resonant Cavity Method

Physical review, 1950-01, Vol.80 (2), p.298-298

Bol, Kees

1950

Volltextzugriff (PDF)

Review 19 -- No Title

The Journal of Asian Studies (pre-1986), 1983, Vol.42 (3), p.643

PETER KEES BOL

1983

Volltextzugriff (PDF)

SUNG; MCKNIGHT (trans.), "The Washing Away of Wrongs" ["Hsi yuan shi lu", by Sung Tz'u (1186-1249)]: "Forensic Medicine in Thirteenth-Century China" (Book Review)

Journal of Asian Studies, 1983, Vol.42 (3), p.643

Kees Bol, Peter

1983

Volltextzugriff (PDF)

The Washing Away of Wrongs [Hsi yuan chi lu, by Sung Tz'u (1186–1249)]: Forensic Medicine in Thirteenth-Century China. Translated and introduced by Brian E. McKnight. Ann Arbor: University of Michigan Center for Chinese Studies, Science, Medicine, and Technology in East Asia no. 1, 1981. xv, 181 pp. Illustrations, Bibliography, Index. $9 (cloth); $6 (paper)

The Journal of Asian studies, 1983-05, Vol.42 (3), p.643-644

Bol, Peter Kees

1983

Volltextzugriff (PDF)

CULTURE AND THE WAY IN ELEVENTH CENTURY CHINA

BOL, PETER KEES

1982

Volltextzugriff (PDF)

The Washing Away of Wrongs [Hsi yuan chi lu, by Sung Tz'u (1186–1249)]: Forensic Medicine in Thirteenth-Century China. Translated and introduced by McKnightBrian E.. Ann Arbor: University of Michigan Center for Chinese Studies, Science, Medicine, and Technology in East Asia no. 1, 1981. xv, 181 pp. Illustrations, Bibliography, Index. $9 (cloth); $6 (paper)

The Journal of Asian Studies, 1983, Vol.42 (3), p.643-644

Bol, Peter Kees

1983

Volltextzugriff (PDF)

Review of "Brian E. McKnight, The Washing Away of Wrongs [Hsi yuan chi lu, by Sung Tz'u (1186–1249)]: Forensic Medicine in Thirteenth-Century China University of Michigan Center for Chinese Studies (1981)"

The Journal of Asian Studies, 1983, Vol.42 (3), p.643-644

Bol, Peter Kees

1983

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(27)

Publikationsform

Sprache

Englisch
(31)
Niederländisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

JNJ-26481585, a Novel “Second-Generation” Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity

Translational PK-PD modeling analysis of MCLA-128, a HER2/HER3 bispecific monoclonal antibody, to predict clinical efficacious exposure and dose

814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity

Phase I dose-escalation study of MCLA-158, a first-in-class bispecific antibody targeting EGFR and LGR5, in metastatic colorectal cancer (CRC)

Abstract OT2-15-01: Updated analysis of MCLA-128 (zenocutuzumab), trastuzumab, and vinorelbine in patients (pts) with HER2 positive/amplified (HER2+) metastatic breast cancer (MBC) who progressed on previous anti-HER2 ADCs

Population Pharmacokinetics of MCLA-128, a HER2/HER3 Bispecific Monoclonal Antibody, in Patients with Solid Tumors

Abstract P185: Preliminary antitumor activity of MCLA-158, an IgG1 bispecific antibody targeting EGFR and LGR5, in advanced head and neck squamous cell carcinoma

The "Localist Turn" and "Local Identity" in Later Imperial China

First-in-human phase 1/2 study of MCLA-128, a full length IgG1 bispecific antibody targeting HER2 and HER3: Final phase 1 data and preliminary activity in HER2+ metastatic breast cancer (MBC)

Clinical activity of MCLA-128 (zenocutuzumab), trastuzumab, and vinorelbine in HER2 amplified metastatic breast cancer (MBC) patients (pts) who had progressed on anti-HER2 ADCs

Clinical activity of MCLA-128 (zenocutuzumab) in combination with endocrine therapy (ET) in ER+/HER2-low, non-amplified metastatic breast cancer (MBC) patients (pts) with ET-resistant disease who had progressed on a CDK4/6 inhibitor (CDK4/6i)

Abstract CT050: A Phase I/II Study of MCLA-128, a full length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients with Solid Tumors

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

Sung Dynasty uses of the I ching

Advances in Electronics and Electron Physics . vol. IX. L. Marton, Ed. Academic Press, New York, 1957. x +347 pp. Illus. $9

THE VELOCITY OF LIGHT AS MEASURED BY THE RESONANT MICROWAVE CAVITY METHOD

Advances in Electronics and Electron Physics. vol. IX

Robert A. Ellis Jr

A Determination of the Speed of Light by the Resonant Cavity Method

Review 19 -- No Title

SUNG; MCKNIGHT (trans.), "The Washing Away of Wrongs" ["Hsi yuan shi lu", by Sung Tz'u (1186-1249)]: "Forensic Medicine in Thirteenth-Century China" (Book Review)

CULTURE AND THE WAY IN ELEVENTH CENTURY CHINA

Review of "Brian E. McKnight, The Washing Away of Wrongs [Hsi yuan chi lu, by Sung Tz'u (1186–1249)]: Forensic Medicine in Thirteenth-Century China University of Michigan Center for Chinese Studies (1981)"

Suchergebnisse filtern